Community-based physician practices will see a ~6% reimbursement increase under the 2026 Medicare Physician Fee Schedule, while hospital-based practices face an ~11% decrease. This represents the first time in years that Community-based physicians are not facing a reduction in reimbursements—and it has immediate implications for how lenders evaluate your debt capacity.
Why it matters
This is not just a fee schedule update. It is a fundamental shift in how lenders will underwrite healthcare services debt in 2026.
- Independent practices gain leverage. A ~6% reimbursement increase directly improves debt service coverage ratios (DSCR), allowing community practices to support higher debt levels at better terms.
- Hospital-employed models lose ground. The ~11% decrease for hospital-based practices widens the economics gap between employment and independent ownership.
- Lender pricing adjusts quickly. Healthcare lenders incorporate Medicare rate changes into their underwriting models within weeks, affecting leverage multiples, interest rates, and covenant cushions.
The numbers behind the change
CMS implemented a dual conversion factor structure for 2026:
- Qualifying participants (QPs): 3.8% increase in the conversion factor
- Non-QPs: 3.3% increase in the conversion factor
When combined with site-of-service differential adjustments, community (non-facility) practices see a net ~6% reimbursement increase, while hospital outpatient departments experience an ~11% decrease.
For a community practice generating $25 million in annual revenue with 60% Medicare payor mix, a 6% increase translates to approximately $900,000 in additional annual cash flow. That additional cash flow supports roughly $4.5 million to $5.4 million in incremental debt capacity, depending on the lender’s required Fixed Charge Coverage Ratio (typically 1.20x for healthcare services).
How lenders incorporate this into underwriting
Healthcare lenders do not wait for actual financial statements to reflect reimbursement changes. They adjust their models prospectively once final rules are released.
Leverage multiples: A practice that previously qualified for 3.5x EBITDA in total debt may now qualify for 4.0x to 4.5x, assuming stable operations and payor mix. The improved Medicare economics reduce perceived risk.
Covenant cushions: Lenders typically require 20% to 25% cushion between projected FCCR and covenant minimums. Higher Medicare reimbursement widens that cushion, reducing covenant violation risk and potentially lowering pricing.
Cost of capital: Improved cash flow metrics translate directly to lower interest rates. A practice with stronger FCCR and covenant cushions can expect pricing 100 to 200 basis points lower than a comparable practice with tighter coverage ratios. On a $30 million facility, that difference represents $300,000 to $600,000 in annual interest savings.
What this means for practice growth
The fee schedule changes create two distinct opportunities for community-based practices.
First, debt capital for tuck-in acquisitions becomes more accessible. Practices pursuing growth through acquisitions of smaller practices now have stronger debt capacity and better terms. The 6% reimbursement increase improves pro forma cash flows for combined entities, allowing lenders to underwrite larger facilities at more favorable pricing. For platforms executing buy-and-build strategies, this translates to more firepower for acquisitions.
Second, practices can refinance expensive private credit debt with lower-cost bank financing. If you borrowed from a private credit fund in 2023 or 2024 at SOFR plus 550 to 650 basis points, you may now qualify for bank debt at SOFR plus 275 to 350 basis points. The improved Medicare reimbursement profile strengthens your credit metrics, making you more attractive to traditional bank lenders who price based on perceived risk. On a $30 million facility, moving from private credit to bank debt can save $600,000 to $800,000+ in annual interest expense.
For practices already independent, this is an opportune time to evaluate financing options. Lenders, including private credit funds, are repricing healthcare services risk downward based on the 2026 fee schedule, and the current interest rate environment remains favorable compared to 2023-2024 levels.
Evaluating your options
Platforms like CAPX allow practices to see how multiple healthcare lenders evaluate their reimbursement profile and debt capacity. Rather than approaching lenders sequentially, practices can assess leverage capacity, pricing, and structure across the market simultaneously.
The 2026 Medicare fee schedule creates a discrete window where independent practices benefit from both improved reimbursement and favorable lender pricing adjustments. Practices with growth plans or refinancing needs should evaluate their options while this dynamic holds.
The bottom line
The 2026 Medicare fee schedule represents the first reimbursement increase for physicians in years, and it directly impacts debt capacity for community-based practices. Lenders are already incorporating the 6% increase into their underwriting models, which translates to higher leverage multiples, lower cost of capital, and better covenant terms. Whether you are pursuing tuck-in acquisitions or looking to refinance expensive private credit debt with bank financing, this is a favorable time to assess your options.
